Local Anesthetics Flashcards
Chloroprocaine (Nesacaine)
Chemical Classification
&
MOA
Ester
Short acting
Intracellular Voltage-Gated Na+ Channel Blocker; Blocks initiation & conduction of
nerve impulses
Chloroprocaine (Nesacaine)
Acid/Base
pKa
Lipid Solubility
Protein Binding
Acid/Base
Weak base
pKa
8.7
Lipid Solubility
Low
Protein Binding
Low
Chloroprocaine (Nesacaine)
Dosing
Max Infiltration Dose:
600 mg
6 mg/kg w/o EPI
14 mg/kg w/ EPI
Chloroprocaine (Nesacaine)
Onset
Duration
Onset
Rapid
Duration
30-45 min
Chloroprocaine (Nesacaine)
Metabolism
&
Elimination
Plasma:
Hydrolysis by plasma cholinesterase enzymes
Metabolite:
Para aminobenzoic acid (PABA)
Allergy Concern
Renal Excretion
Fastest metabolism rate by 3.5x
Chloroprocaine (Nesacaine)
Side Effects
&
Considerations
Prolonged effects d/t ↓ hydrolysis occur in hepatic disease & ↑BUN
↑ sensitivity d/t
↓ PChE levels;
↓protein levels
Procaine (Novocaine)
Chemical Classification
&
MOA
Ester
Short acting
Intracellular Voltage-Gated Na+ Channel Blocker; Blocks initiation & conduction of
nerve impulses
Procaine (Novocaine)
Acid/Base
pKa
Lipid Solubility
Protein Binding
Acid/Base
Weak Base
pKa
8.9
Lipid Solubility
0.6
Protein Binding
6%
Procaine (Novocaine)
Dosing
Max Infiltration Dose:
500 mg
7 mg/kg w/o EPI
8.5 mg/kg w/ EPI
Procaine (Novocaine)
Onset
Duration
Onset
Slow
Duration
45-60 min
Procaine (Novocaine)
Metabolism
&
Elimination
Plasma:
Hydrolysis by plasma cholinesterase enzymes
**Metabolite: **
Para aminobenzoic acid (PABA)
Allergy Concern
Renal Excretion
Metabolism Rate - Intermediate
Procaine (Novocaine)
Side Effects
&
Considerations
Prolonged effects d/t
↓ hydrolysis occurs in hepatic disease & ↑BUN
↑ sensitivity d/t
↓ PChE levels;
↓protein levels
Tetracaine (Dicaine)
Chemical Classification
&
MOA
Ester
Long acting
Intracellular Voltage-Gated Na+ Channel Blocker; Blocks initiation & conduction of
nerve impulses
Tetracaine (Dicaine)
Acid/Base
pKa
Lipid Solubility
Protein Binding
Acid/Base
Weak Base
pKa
8.5
Lipid Solubility
80
Protein Binding
76%
Tetracaine (Dicaine)
Dosing
Local Total Max Dose:
100 mg (topical)
3 mg/kg w/o EPI
3 mg/kg w/ EPI
Tetracaine (Dicaine)
Onset
Duration
Onset
Slow
Duration
60-180 min
Tetracaine (Dicaine)
Metabolism
&
Elimination
Plasma:
Hydrolysis by plasma cholinesterase enzymes
Metabolite:
Para aminobenzoic acid (PABA)
Allergy Concern
Renal Excretion
Metabolism Rate - Slowest
Tetracaine (Dicaine)
Side Effects
&
Considerations
No vasodilatory activity
Prolonged effects d/t
↓ hydrolysis occurs in hepatic disease & ↑BUN
↑ sensitivity d/t
↓ PChE levels;
↓protein levels
Liposome; used to upload ↑ amount of LA into molecule & have consistent release of
LA in
Other formulation:
Tetracaine Gel 4%
Lidocaine (Xylocaine)
Chemical Classification
&
MOA
Amide - Intermediate Acting
Intracellular Voltage-Gated Na+ Channel Blocker; Blocks initiation & conduction of
nerve impulses
Lidocaine (Xylocaine)
Acid/Base
pKa
Lipid Solubility
Protein Binding
Acid/Base
Weak Base
pKa
7.9
Lipid Solubility
2.9
Protein Binding
70%
pKa closest to physiologic pH = faster OOA